Etonogestrel–ethinylestradiol vaginal ring for hormonal contraception

References

• Benagiano G, Bastianelli C, Farris M. Contraception today. Ann. NY. Acad. Sci.1092, 1–32 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am. J. Obstet. Gynecol.180, 276–279 (1999).
   PubMed Web of Science ®Google Scholar
• van den Heuvel MW, van Bragt AJM, Alnabawy AKM, Kaptein MCJ. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception72, 168–174 (2005).
   PubMed Web of Science ®Google Scholar
• Creinin MD, Meyn LA, Borgatta L et al. Multicenter comparison of the contraceptive ring and patch. A randomized controlled trial. Obstet. Gynecol.111, 267–277 (2008).
   PubMed Web of Science ®Google Scholar
• Roumen FJME. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception75, 420–429 (2007).
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst. Rev.1, CD003552 (2008).
   Google Scholar
• Timmer CJ, Mulders TMT. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin. Pharmacokinet.39, 233–242 (2000).
   PubMed Web of Science ®Google Scholar
• Mulders TMT, Dieben TOM. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil. Steril.75, 865–870 (2001).
   PubMed Web of Science ®Google Scholar
• Duijkers IJM, Klipping C, Verhoeven CHJ, Dieben TOM. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Hum. Reprod.19, 2668–2673 (2004).
   PubMed Web of Science ®Google Scholar
• Duijkers IJM, Verhoeven CHJ, Dieben TOM, Klipping C. Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pre-treatment cycle. Hum. Reprod.19, 2674–2679 (2004).
   PubMed Web of Science ®Google Scholar
• Roumen FJME, Dieben TOM. Comparison of uterine concentrations of ethinylestradiol and etonogestrel – after use of a contraceptive vaginal ring and an oral contraceptive. Fertil. Steril.85, 57–62 (2006).
   PubMed Web of Science ®Google Scholar
• Duijkers I, Killick S, Bigrigg A, Dieben TOM. A comparative study on the effects of a contraceptive vaginal ring NuvaRing® and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function. Eur. J. Contracept. Reprod. Health Care9, 131–140 (2004).
   PubMed Web of Science ®Google Scholar
• Elkind-Hirsch KE, Darensbourg C, Ogden B, Ogden LF, Hindelang P. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive. Contraception76, 348–356 (2007).
   PubMed Web of Science ®Google Scholar
• Haring T, Mulders TMT. The combined contraceptive ring NuvaRing® and spermicide co-medication. Contraception67, 271–272 (2003).
   PubMed Web of Science ®Google Scholar
• Verhoeven CHJ, van den Heuvel MW, Mulders TMT, Dieben TOM. The contraceptive vaginal ring, NuvaRing®, and antimycotic co-medication. Contraception69, 129–132 (2004).
   PubMed Web of Science ®Google Scholar
• Verhoeven CHJ, Dieben TOM. The combined contraceptive vaginal ring, NuvaRing®, and tampon co-usage. Contraception69, 197–199 (2004).
   PubMed Web of Science ®Google Scholar
• Roumen FJME, Apter D, Mulders TMT, Dieben TOM. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum. Reprod.16, 469–475 (2001).
   PubMed Web of Science ®Google Scholar
• Dieben TOM, Roumen FJME, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet. Gynecol.100, 585–593 (2002).
   PubMed Web of Science ®Google Scholar
• Oddsson K, Leifels-Fischer B, de Melo NR et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception71, 176–182 (2005).
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Nisand I, Bastianelli C et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 mug ethinyl estradiol and 3 mg of drospirenone. Contraception74, 451–457 (2006).
   PubMed Web of Science ®Google Scholar
• Roumen FJME, op ten Berg MMT, Hoomans EHM. The combined contraceptive vaginal ring (NuvaRing®): first experience in daily clinical practice in the Netherlands. Eur. J. Contracept. Reprod. Health Care11, 14–22 (2006).
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Hund M. Clinical experience with NuvaRing® in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages. Eur. J. Contracept. Reprod. Health Care12, 240–247 (2007).
   PubMed Web of Science ®Google Scholar
• Brucker C, Karck U, Merkle E. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing®: Results of clinical experience in Germany. Eur. J. Contracept. Reprod. Health Care13, 31–38 (2008).
   PubMed Web of Science ®Google Scholar
• Bruni V, Pontello V, Luisi S, Petraglia F. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing®. Eur. J. Obstet. Gynecol. Reprod. Biol.139, 65–71 (2008).
   PubMed Web of Science ®Google Scholar
• Oddsson K, Leifels-Fischer B, Wiel-Masson D et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 µg ethinylestradiol and 150 µg levonorgestrel: a randomized trial. Hum. Reprod.20, 557–562 (2005).
   PubMed Web of Science ®Google Scholar
• Milsom I, Lete I, Bjertnaes A et al. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone Hum. Reprod.21, 2304–2311 (2006).
   PubMed Web of Science ®Google Scholar
• Westhoff C, Osborne LM, Schafer JE, Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstet. Gynecol.106, 89–96 (2005).
   PubMed Web of Science ®Google Scholar
• Veres S, Miller L, Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet. Gynecol.104, 555–563 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception74, 220–223 (2006).
   PubMed Web of Science ®Google Scholar
• Miller L, Verhoeven CH, Hout J. Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet. Gynecol.106, 473–482 (2005).
   PubMed Web of Science ®Google Scholar
• O’Connell KJ, Osborne LM, Westhoff C. Measured and reported weight change for women using a vaginal contraceptive ring vs a low-dose oral contraceptive. Contraception72, 323–327 (2005).
   PubMed Web of Science ®Google Scholar
• Schafer JE, Osborne LM, Davis AR, Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception73, 488–492 (2006).
   PubMed Web of Science ®Google Scholar
• Guida M, Di Spiezio Sardo A, Bramante S et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum. Reprod.20, 1100–1106 (2005).
   PubMed Web of Science ®Google Scholar
• Magnusdóttir EM, Bjarnadóttir RI, Önundarson PT et al. The contraceptive vaginal ring (NuvaRing®) and hemostasis: a comparative study. Contraception69, 461–467 (2004).
   PubMed Web of Science ®Google Scholar
• Tuppurainen M, Klimscheffskij R, Venhola M, Dieben TOM. The combined contraceptive vaginal ring (NuvaRing®) and lipid metabolism: a comparative study. Contraception69, 389–394 (2004).
   PubMed Web of Science ®Google Scholar